Brief: Novozymes Q4 EBITDA DKK 1,320 Million

Novozymes A/S

01/02/2024 07:00

Feb 01 (Reuters) - Novozymes Q4 gross margin 54.3%.
* Q4 net income DKK 695 million vs. estimate DKK 918 million
* Q4 EBIT margin 20.7%
* Q4 EPS DKK 2.52
* Q4 EBIT DKK 955 million
* Q4 sales DKK 4,603 million vs. estimate DKK 4,630 million